Taiwan Industry Reports
Industry Type:   Title:  

Raw Material Medicine Manufacturing US$ 100
Jul-2022 Doc #36540
Printed Page Length : 15 pages
Number of Tables : 3
Number of Figures: 1
Market Overview
Demand in the end market remains strong, suggesting active pharmaceutical ingredient firms with niche products will benefit from the restructuring process of the pharmaceutical supply chains in Europe and the United States and generic drug companies in Taiwan. Consequently, the industry climate will be slightly favorable in the second half of 2022.

Copyright (c) 2018 All Rights Reserved by
Taiwan Institute of Economic Research
Taiwan Industry Economics Services
Address: 4Fl., 16-8, Tehui St., Taipei, Taiwan
TEL: 886-2-25865000 ext469; FAX: 886-2-25935543